Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III.
paper
Cited
Public
- Authors
- Hasin, Deborah S; Kerridge, Bradley T; Saha, Tulshi D; Huang, Boji; Pickering, Roger; Smith, Sharon M; Jung, Jeesun; Zhang, Haitao; Grant, Bridget F
- Year
- 2016
- Journal
- The American journal of psychiatry
- PMID
- 26940807
- DOI
- 10.1176/appi.ajp.2015.15070907
- PMCID
- PMC5026387
OBJECTIVE: Attitudes toward marijuana are changing, the prevalence of DSM-IV cannabis use disorder has increased, and DSM-5 modified the cannabis use disorder criteria. Therefore, updated information is needed on the prevalence, demographic characteristics, psychiatric comorbidity, disability, and treatment for DSM-5 cannabis use disorder. METHOD: In 2012-2013, 36,309 participants β₯18 years old were interviewed in the National Epidemiologic Survey on Alcohol and Related Conditions-III. Psychiatric and substance use disorders were assessed with the Alcohol Use Disorders and Associated Disabilities Interview Schedule-5. RESULTS: The prevalences of 12-month and lifetime cannabis use disorder were 2.5% and 6.3%. Among those with 12-month and lifetime diagnoses, the mean days of marijuana use per year were 225.3 (SE=5.7) and 274.2 (SE=3.8). The odds of 12-month and lifetime cannabis use disorder were higher for men, Native Americans, unmarried individuals, those with low incomes, and young adults (e.g., among those age 18-24 years versus β₯45: odds ratio for 12-month disorder, 7.2; 95% confidence interval, 5.5-9.5). Cannabis use disorder was associated with other substance use disorders, affective disorders, anxiety, and personality disorders. Twelve-month cannabis use disorder was associated with disability. As disorder severity increased, virtually all associations became stronger. Only 13.2% with lifetime cannabis use disorder participated in 12-step programs or professional treatment. CONCLUSIONS: DSM-5 cannabis use disorder is prevalent, associated with comorbidity and disability, and largely untreated. Findings suggest the need to improve prevention and educate the public, professionals, and policy makers about possible harms associated with cannabis use disorders and available interventions.
Prevalence of 12-Month DSM-5 Cannabis Use Disorder in the United States, by SeverityaPrevalences reflect numbers adjusted for nonresponse, and weighted to represent the U.S. population based on the 2012 American Community Survey. Total n=36,309; Males n=15,862; Females n=20,447; Age 18β29 n=8,126; Age 30β44 n=10,135; Age 45+ n=5,806.
1β20 of 35
Next β
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A systematic review of the prevalence and correlates of mental and substance use disorders in first nations peoples in Australia, New Zealand, Canada and the United States of America. | Basit TA et al. | β | 2026 | β |
| Attentional bias in people with moderate-to-severe cannabis use disorder. | Quinones-Valera M et al. | β | 2026 | β |
| Cannabis and Mental Health: A Review. | Kansagara D et al. | β | 2026 | β |
| Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta-analysis. | Halicka M et al. | β | 2026 | β |
| Effectiveness of cognitive behavioral therapy for harmful cannabis use: a systematic review and meta-analysis. | Ullah S et al. | β | 2026 | β |
| Estimating thresholds for risk of cannabis use disorder using standard delta-9-tetrahydrocannabinol (THC) units. | Lees Thorne R et al. | β | 2026 | β |
| Genome-wide association studies of lifetime and frequency of cannabis use in 131,895 individuals. | Thorpe HHA et al. | β | 2026 | β |
| "Medical Cannabis": Advising Patients While Navigating Medical Ethics and Limited Evidence. | South AM et al. | β | 2026 | β |
| Polysubstance Use Disorders in Individuals with Cannabis Use Disorder: Results from a Nationally Representative Sample (National Epidemiologic Survey on Alcohol and Related Conditions). | Wilkialis L et al. | β | 2026 | β |
| Racial diversity in cannabis use disorder research: A systematic review. | Reid MR et al. | β | 2026 | β |
| Test-retest reliability of mgTHC consumption in the self-administered Cannabis Exposure Index (CEI). | Hasin DS et al. | β | 2026 | β |
| Therapeutic Use of Cannabis and Cannabinoids: A Review. | Hsu M et al. | β | 2026 | β |
| Trends in the diagnostic prevalence of cannabis-related disorders and co-occurring psychiatric disorders in adolescents: analysis of German health insurance data from 2013 to 2022. | Zarour A et al. | β | 2026 | β |
| What is a "Cannabis User"? | Fisher R | β | 2026 | β |
| Ξ<sup>9</sup>-Tetrahydrocannabinol Alters Limbic and Frontal Functional Brain Connectomes Among Young Adult Cannabis Users. | Anderson Z et al. | β | 2026 | β |
| Absence of Evidence for Sustained Effects of Daily Cannabidiol Administration on Anandamide Plasma Concentration in Individuals with Cocaine Use Disorder: Exploratory Findings from a Randomized Controlled Trial. | Hebert FO et al. | β | 2025 | β |
| An Analysis of 16-Year Trends in Cannabis Use Disorder Treatment: Predictors, Barriers, and Utilization Patterns. | Graves BD et al. | β | 2025 | β |
| Assessment and Management of Concurrent Substance Use in Patients Receiving Repetitive Transcranial Magnetic Stimulation for Depressive, Obsessive-Compulsive, Psychotic, and Trauma-Related Disorders: A Delphi Consensus Study and Guideline. | Tang VM et al. | β | 2025 | β |
| Association of childhood mental health and cognition with longitudinal patterns of cannabis problems in adolescence. | Lees Thorne R et al. | β | 2025 | β |
| Cannabinoid hyperemesis syndrome in pregnancy: a case series and review. | Hanley S et al. | β | 2025 | β |
| Cannabis and psychopathology: 2024 Snapshot of a meandering journey. | Mahintamani T et al. | β | 2025 | β |
| Cannabis effects on cardiovascular health: Current evidence, gaps in knowledge, and future research directions. | Mahmoud AK et al. | β | 2025 | β |
| Cannabis legalization and cannabis use disorder in United States Veterans Health Administration patients with and without psychiatric disorders, 2005-2022: a repeated cross-sectional study. | Hasin DS et al. | β | 2025 | β |
| Cannabis or Cannabinoids for the Management of Chronic Noncancer Pain: Best Practice Advice From the American College of Physicians. | Kansagara D et al. | β | 2025 | β |
| Cannabis use and binge eating among young adults: The role of depressive symptoms. | Elran-Barak R et al. | β | 2025 | β |
| Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013. | Hasin DS et al. | β | 2025 | β |
| Cannabis Use and Cardiovascular Risk Among Healthy Young Adults: Cause or Confounding? | Cardone A et al. | β | 2025 | β |
| Cannabis Use and Clinical Outcomes in Adolescents and Young Adults With Diabetes: The SEARCH for Diabetes in Youth Study. | Roberts AJ et al. | β | 2025 | β |
| Cannabis use disorder risks among Medicaid enrollees with comorbid psychiatric illnesses: 2012-2021. | Hou J et al. | β | 2025 | β |
| Cannabis use patterns and different phenotypes in relation to other drugs use: latent class analyses from the Sao Paulo Megacity Mental Health Survey. | Silveira CM et al. | β | 2025 | β |
| Cannabis Use Patterns in First Episode Psychosis and Schizophrenia: A Scoping Review and Case Series | Jin JW et al. | β | 2025 | β |
| Classifying opioid use disorder based on diagnostic criteria items using cluster analysis. | Birla S et al. | β | 2025 | β |
| Concurrent and prospective relations between aberrant stress-induced frontal alpha asymmetry and cannabis use disorder. | Schermitzler BS et al. | β | 2025 | β |
| Daily Assessment of Positive and Negative Cannabis Use Expectancies in Young Adult Cannabis and Tobacco Co-Users: Differences by Sociodemographics, Mental Health Symptoms, and Possible Cannabis Use Disorder. | Romm KF et al. | β | 2025 | β |
| Detection of serum alterations in polysubstance use patients by FT-Raman spectroscopy. | ΓnΓΌbol B et al. | β | 2025 | β |
| Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta-analysis. | Halicka M et al. | β | 2025 | β |
| Effect of mobile-based ecological momentary motivational enhancement therapy on cannabis use temptation and dependence severity among Iranian young adults with cannabis use disorder: A randomized clinical trial. | Darharaj M et al. | β | 2025 | β |
| Effects of legal access versus illegal market cannabis on use and mental health: A randomized controlled trial. | Baltes-Flueckiger L et al. | β | 2025 | β |
| Effects of Trauma Cue Exposure and Posttraumatic Stress Disorder (PTSD) on Affect and Cannabis Craving in Cannabis Users With Trauma Histories: Use of Expressive Writing as an Online Cue-Reactivity Paradigm: Effets de l'exposition aux signaux traumatiques et du SSPT sur l'affect et le besoin de cannabis chez les consommateurs de cannabis ayant des antΓ©cΓ©dents de traumatismes : utilisation de l'Γ©criture expressive comme paradigme de rΓ©activitΓ© en ligne. | DeGrace S et al. | β | 2025 | β |
| "If You Need to Light Up β¦ You Gotta Do What You Gotta Do": A Qualitative Study of Adolescent Attitudes Towards Cannabis Use and Comparison with Alcohol Attitudes. | Clement A et al. | β | 2025 | β |
| Latent Classes of Comorbid Substance Use and Internalizing and Externalizing Symptoms and Their Stability in U.S. Adults Over Time: Findings from the PATH Study Waves 1-3 (2013-2016). | Blondino CT et al. | β | 2025 | β |
| Longitudinal study of risk factors predicting cannabis use disorder in UK young adults and adolescents. | Skumlien M et al. | β | 2025 | β |
| Monthly patterns of depressive symptoms and substance use and their relation to longer-term hazardous substance use and mental health problems: Examining mutual maintenance using monthly data from young adults. | Rhew IC et al. | β | 2025 | β |
| Patterns of past month cannabis consumption and cannabis use disorder - Insights from a nationally representative survey. | Kritikos AF et al. | β | 2025 | β |
| Prevalence of Cannabis Use Disorder: A Meta-Analysis of Population Surveys. | Boness CL et al. | β | 2025 | β |
| Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder. | Brunette MF et al. | β | 2025 | β |
| Relative Risk of All-Cause Mortality Associated With Cannabis Use: A Systematic Review and Meta-Analysis of Cohort Studies. | Alimoradi Z et al. | β | 2025 | β |
| Risk of Cannabis Use Disorder in Chronic Pain: Longitudinal Links to Pain Outcomes. | Mun CJ et al. | β | 2025 | β |
| Safety considerations for patients using cannabis. | Dugan SE | β | 2025 | β |
| The Longitudinal Association of Cumulative Depression With Cannabis Use Disorder Among Young Adults. | Rhew IC et al. | β | 2025 | β |
| Trends in cannabis use disorder and treatment by race and ethnicity, 2002-2019. | Triguero Roura M et al. | β | 2025 | β |
| Written Exposure Therapy for PTSD Integrated with Cognitive Behavioral Coping Skills for Cannabis Use Disorder After Recent Sexual Assault: A Case Series. | Hahn CK et al. | β | 2025 | β |
| A mobile health intervention for emerging adults with regular cannabis use: A micro-randomized pilot trial design protocol. | Coughlin LN et al. | β | 2024 | β |
| A national study of clinical discussions about cannabis use among Veteran patients prescribed opioids. | Zaman T et al. | β | 2024 | β |
| Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study. | Wang W et al. | β | 2024 | β |
| Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004-2019. | Mauro PM et al. | β | 2024 | β |
| A Systematic Review of Delta-9-Tetrahydrocannabinol (β9-THC) in Astrocytic Markers. | Ramos-JimΓ©nez C et al. | β | 2024 | β |
| A Systematic Review of the Molecular and Cellular Alterations Induced by Cannabis That May Serve as Risk Factors for Bipolar Disorder. | Delgado-Sequera A et al. | β | 2024 | β |
| Biological sex and hormonal contraceptive associations with drug cue reactivity in cannabis use disorder. | Macatee RJ et al. | β | 2024 | β |
| Cannabinoid Hyperemesis Syndrome (CHS) - An emerging gastrointestinal disorder and clinical challenge. | McFee RB | β | 2024 | β |
| Cannabis Dependence is Associated with Reduced Hippocampal Subregion Volumes Independently of Sex: Findings from an ENIGMA Addiction Working Group Multi-Country Study. | Lorenzetti V et al. | β | 2024 | β |
| Cannabis Laws and Utilization of Medications for the Treatment of Mental Health Disorders. | Bradford AC et al. | β | 2024 | β |
| Cannabis use and social anxiety disorder in emerging adulthood: Results from a nationally representative sample. | Single A et al. | β | 2024 | β |
| Cannabis use disorder increases risk of large-artery atherosclerotic stroke and migraine with aura through mendelian randomization study. | Dong L et al. | β | 2024 | β |
| Cannabis use in adolescents and anxiety symptoms and disorders: a systematic review and meta-analysis. | Lowe DJE et al. | β | 2024 | β |
| Cannabis use in liver transplant candidates and recipients. | Kriss M et al. | β | 2024 | β |
| Decomposing the late positive potential to cannabis cues in regular cannabis users: A temporal-spatial principal component analysis. | Preston TJ et al. | β | 2024 | β |
| Determining the diagnostic cut-off on the Chinese version of severity of dependence scale for cannabis. | Chung AKK et al. | β | 2024 | β |
| Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol. | Khazaee-Pool M et al. | β | 2024 | β |
| Discriminative validity of a substance use symptom checklist for moderate-severe DSM-5 cannabis use disorder (CUD) in primary care settings. | Hamilton LK et al. | β | 2024 | β |
| Effects of Recreational Cannabis Legalization on Mental Health: Scoping Review. | Fortier A et al. | β | 2024 | β |
| Electronic interventions in primary care to address substance use: A systematic review. | Villanueva-Blasco VJ et al. | β | 2024 | β |
| Expressive Writing About One's Trauma Increases Accessibility of Cannabis Information in Memory Among Trauma-Exposed Individuals. | DeGrace S et al. | β | 2024 | β |
| Extending Gender- and Sex-Based Analyses in Cannabis Research: Findings from an Online Sample of Gender Diverse Young Adult Consumers. | Struble CA et al. | β | 2024 | β |
| Genetic influences and causal pathways shared between cannabis use disorder and other substance use traits. | Galimberti M et al. | β | 2024 | β |
| Genome-wide DNA methylation analysis of cannabis use disorder in a veteran cohort enriched for posttraumatic stress disorder. | Garrett ME et al. | β | 2024 | β |
| Lifetime use of alcohol and cannabis among U.S. adolescents across age: Exploring differential patterns by sex and race/ethnicity using the 2019 NSDUH data. | Farokhnia M et al. | β | 2024 | β |
| Prevalence and correlates of positive parental attitudes towards cannabis use and use intention in Australia during 2016 and 2019. | Chiu V et al. | β | 2024 | β |
| ReBandit: Random Effects Based Online RL Algorithm for Reducing Cannabis Use. | Ghosh S et al. | β | 2024 | β |
| State of the Science: Treatment of comorbid posttraumatic stress disorder and substance use disorders. | Back SE et al. | β | 2024 | β |
| The distribution of neurotransmitters in the brain circuitry: Mesolimbic pathway and addiction. | Ebrahimi MN et al. | β | 2024 | β |
| Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations. | Bahji A et al. | β | 2024 | β |
| Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019. | Livne O et al. | β | 2024 | β |
| "Weeding out" violence? Translational perspectives on the neuropsychobiological links between cannabis and aggression. | Bortolato M et al. | β | 2024 | β |
| Adult use of highly-potent Ξ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021. | Hasin DS et al. | β | 2023 | β |
| A guided digital intervention to reduce cannabis use: The ICan randomized controlled trial. | Olthof MIA et al. | β | 2023 | β |
| An Interpretable and Predictive Connectivity-Based Neural Signature forΒ ChronicΒ Cannabis Use. | Kulkarni KR et al. | β | 2023 | β |
| Assessing the Impact of Recreational Cannabis Legalization on Cannabis Use Disorder and Admissions to Treatment in the United States. | Aletraris L et al. | β | 2023 | β |
| Association Between Cannabis and Violence in Community-Dwelling Patients With Severe Mental Disorders: A Cross-sectional Study Using Machine Learning. | Hudon A et al. | β | 2023 | β |
| Association Between Markers of Vulnerability for Cannabis-Related Harms and Source of Supply: Secondary Analysis of a Representative Population Survey. | Drouin S et al. | β | 2023 | β |
| Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies. | Solmi M et al. | β | 2023 | β |
| Brief Interventions for Cannabis Using Adolescents. | Winters KC et al. | β | 2023 | β |
| Brief Interventions for Cannabis Using Adolescents. | Winters KC et al. | β | 2023 | β |
| Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks. | Ang SP et al. | β | 2023 | β |
| Cannabis Use Disorder in Adolescents. | Hashemi D et al. | β | 2023 | β |
| Cannabis Use Disorder in Adolescents. | Hashemi D et al. | β | 2023 | β |
| Cannabis use prevalence, patterns, and reasons for use among patients with cancer and survivors in a state without legal cannabis access. | McClure EA et al. | β | 2023 | β |
| Chronic pain, cannabis legalisation, and cannabis use disorder among patients in the US Veterans Health Administration system, 2005 to 2019: a repeated, cross-sectional study. | Hasin DS et al. | β | 2023 | β |
| Daily Ξ<sup>9</sup>-Tetrahydrocannabinol and Withdrawal Increase Dopamine D<sub>1</sub>-D<sub>2</sub> Receptor Heteromer toΒ Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa OpioidΒ Receptor Mechanism. | Hasbi A et al. | β | 2023 | β |
| Differences in internalizing symptoms between those with and without Cannabis Use Disorder among HBCU undergraduate students. | Keen L et al. | β | 2023 | β |
| Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. | Shmulewitz D et al. | β | 2023 | β |
| Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia-spectrum disorders? | Yeap ZJS et al. | β | 2023 | β |
| Effects of cannabis regulation in Switzerland: Study protocol of a randomized controlled trial. | Baltes-Flueckiger L et al. | β | 2023 | β |
| Emerging Adult Perceptions of Cannabis Consumption Post-Legalization: Considering Age and Sex Differences. | Harris-Lane LM et al. | β | 2023 | β |
| Evaluation of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Questionnaire and its Relations to Cannabis-Related Problems. | Gette JA et al. | β | 2023 | β |
| Exponentiated model of drug demand is preferred over exponential models in people with daily/near daily cannabis use. | Tolbert PT et al. | β | 2023 | β |
| Impact of Adolescent Cannabis Use on Neurocognitive and Brain Development. | Scott JC | β | 2023 | β |
| Impact of Adolescent Cannabis Use on Neurocognitive and Brain Development. | Scott JC | β | 2023 | β |
| Increasing risk of cannabis use disorder among U.S. veterans with chronic pain: 2005-2019. | Mannes ZL et al. | β | 2023 | β |
| Incremental Predictive Validity of the Dualistic Model of Passion for Cannabis Use Among College Undergraduate Students With and Without a Cannabis Use Disorder. | Davis AK et al. | β | 2023 | β |
| "I still partly think this is bullshit": A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting. | Collins AB et al. | β | 2023 | β |
| Managing substance use in patients receiving therapeutic repetitive transcranial magnetic stimulation: A scoping review. | Tang VM et al. | β | 2023 | β |
| Marijuana Use is Not a Contraindication for Tranexamic Acid Utilization in Lumbar Spine Surgery. | Jakoi AM et al. | β | 2023 | β |
| Molecular brain differences and cannabis involvement: A systematic review of positron emission tomography studies. | Xu H et al. | β | 2023 | β |
| Negative Affect Regulation and Marijuana Use in College Students: Evaluating the Mediating Roles of Coping and Sleep Motives. | Livingston NR et al. | β | 2023 | β |
| Neurophysiological error processing and addiction self-awareness correlates of reduced insight in cannabis use disorder. | Macatee RJ et al. | β | 2023 | β |
| Planned versus unplanned drinking and cannabis use: Do facets of trait impulsivity influence daily risk? | Waddell JT et al. | β | 2023 | β |
| Psychometric Performance of a Substance Use Symptom Checklist to Help Clinicians Assess Substance Use Disorder in Primary Care. | Matson TE et al. | β | 2023 | β |
| Sex differences in Cannabis use disorder and associated psychosocial problems among US adults, 2012-2013. | Gutkind S et al. | β | 2023 | β |
| Sex differences in the subjective and reinforcing effects of smoked cannabis. | Lake S et al. | β | 2023 | β |
| State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019. | Hasin DS et al. | β | 2023 | β |
| The Impact of religiosity/spirituality on slowing the progression of substance use: Based on the National Epidemiological Survey of Alcohol and Related Conditions (NESARC-III). | Hassan AN et al. | β | 2023 | β |
| The long-term effects of adolescent Ξ9-tetrahydrocannabinol on brain structure and function assessed through neuroimaging techniques in male and female rats. | Orihuel J et al. | β | 2023 | β |
| Transcriptome-wide association study by different approaches reveals candidate causal genes for cannabis use disorder. | Gao J et al. | β | 2023 | β |
| Transitions in Prescription Benzodiazepine Use and Misuse and in Substance Use Disorder Symptoms Through Age 50. | McCabe SE et al. | β | 2023 | β |
| Trends in Cannabis-positive Urine Toxicology Test Results: US Veterans Health Administration Emergency Department Patients, 2008 to 2019. | Fink DS et al. | β | 2023 | β |
| Unhealthy behaviors associated with mental health disorders: a systematic comparative review of diet quality, sedentary behavior, and cannabis and tobacco use. | Johnstad PG | β | 2023 | β |
| A difference-in-difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004-17. | Weinberger AH et al. | β | 2022 | β |
| Admissions to substance use treatment facilities for cannabis use disorder, 2000-2017: Does legalization matter? | Rhee TG et al. | β | 2022 | β |
| A network approach to substance use, internalizing, and externalizing comorbidity in U.S. adults. | Blondino CT et al. | β | 2022 | β |
| Assessing Increases in Cannabis-Related Diagnoses in US Hospitals by Regional Policy Status. | Pottieger M et al. | β | 2022 | β |
| Association of a Positive Drug Screening for Cannabis With Mortality and Hospital Visits Among Veterans Affairs Enrollees Prescribed Opioids. | Keyhani S et al. | β | 2022 | β |
| Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence. | Kuhns L et al. | β | 2022 | β |
| Associations of Current and Remitted Cannabis Use Disorder With Health-related Quality of Life and Employment Among US Adults. | Rhee TG et al. | β | 2022 | β |
| Attitudes and Beliefs Toward Cannabis Before Recreational Legalization: A Cross-Sectional Study of Community Adults in Ontario. | Turna J et al. | β | 2022 | β |
| Cannabis and binge alcohol use among older individuals with major depressive episode. | Choi NG et al. | β | 2022 | β |
| Cannabis use disorder severity and sleep quality among undergraduates attending a Historically Black University. | Keen L et al. | β | 2022 | β |
| Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemic. | Assaf RD et al. | β | 2022 | β |
| Clinical management of cannabis withdrawal. | Connor JP et al. | β | 2022 | β |
| Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study. | Quick CR et al. | β | 2022 | β |
| Comparing Cannabis Use Disorder in the General Population with Cannabis Treatment Seekers Using Multi-Source National Datasets: Who Receives Treatment? | Mongan D et al. | β | 2022 | β |
| Consideration of sex and gender differences in addiction medication response. | McKee SA et al. | β | 2022 | β |
| Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use. | Fink DS et al. | β | 2022 | β |
| Contingency Management for Treatment of Cannabis Use Disorder in Co-Occurring Mental Health Disorders: A Systematic Review. | Rodas JD et al. | β | 2022 | β |
| Correlates of cannabis use disorder in the United States: A comparison of logistic regression, classification trees, and random forests. | Dell NA et al. | β | 2022 | β |
| Daily cannabis use, cannabis use disorder, and any medical cannabis use among US adults: Associations within racial, ethnic, and sexual minoritized identities in a changing policy context. | Mauro PM et al. | β | 2022 | β |
| Daily Marijuana Use Predicts HIV Seroconversion Among Black Men Who Have Sex with Men and Transgender Women in Atlanta, GA. | Knox J et al. | β | 2022 | β |
| Editorial: Cannabis and the law. | Dumais A et al. | β | 2022 | β |
| Emerging pharmacological treatments for cannabis use disorder. | Danilewitz M | β | 2022 | β |
| Epidemiology of eating disorders among US adults. | Udo T et al. | β | 2022 | β |
| Equity in Coverage of Local Cannabis Control Policies in California, 2020β2021. | Matthay EC et al. | β | 2022 | β |
| Evaluating the relationship between industry sponsorship and conflicts of interest among systematic review authors on treatments for cannabis use disorder. | Carr M et al. | β | 2022 | β |
| Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta-review of meta-analyses. | Dellazizzo L et al. | β | 2022 | β |
| Getting High or Getting By? An Examination of Cannabis Motives, Cannabis Misuse, and Concurrent Psychopathology in a Sample of General Community Adults. | Scarfe ML et al. | β | 2022 | β |
| Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis. | Robinson T et al. | β | 2022 | β |
| Impact of a computerized distress intolerance intervention on electrocortical reactivity to cannabis and threat cues: A randomized controlled trial. | Macatee RJ et al. | β | 2022 | β |
| Impact of acute stress on neural indices of positive and negative reinforcement processing in cannabis users. | Preston TJ et al. | β | 2022 | β |
| Impact of cannabinoids on pregnancy, reproductive health, and offspring outcomes. | Lo JO et al. | β | 2022 | β |
| Incidence of inpatient cases with mental disorders due to use of cannabinoids in Germany: a nationwide evaluation. | Gahr M et al. | β | 2022 | β |
| Intricacies of Researching Cannabis Use and Use Disorders Among Veterans in the United States. | Striley CW et al. | β | 2022 | β |
| I Smoke Alone: Indirect Effects of Solitary Cannabis Use on Negative Consequences Through Coping Motives. | Okey SA et al. | β | 2022 | β |
| Longitudinal associations between justice sensitivity, nonsuicidal self-injury, substance use, and victimization by peers. | Bilgin A et al. | β | 2022 | β |
| Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder. | Livingston NA et al. | β | 2022 | β |
| Long-term cannabis use and preparedness for ageing. | Hasin D | β | 2022 | β |
| Maturing out of alcohol and cannabis co-use: A test of patterns and personality predictors. | Waddell JT et al. | β | 2022 | β |
| Medical Cannabis and Past-Year Cannabis Use Disorder Among Adult Recreational Users in the United States: Results From a Nationally Representative Sample. | Rubin-Kahana DS et al. | β | 2022 | β |
| Momentary patterns of alcohol and cannabis co-use in college students: Assessing the temporal association with anxiety. | Phillips KT et al. | β | 2022 | β |
| Patients admitted to treatment for substance use disorder in Norway: a population-based case-control study of socio-demographic correlates and comparative analyses across substance use disorders. | Amundsen EJ et al. | β | 2022 | β |
| Predictors of no, low and frequent emergency department use for any medical reason among patients with cannabis-related disorders attending Quebec (Canada) addiction treatment centres. | Fleury MJ et al. | β | 2022 | β |
| Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III). | Browne KC et al. | β | 2022 | β |
| Psychiatric and substance use disorders in a predominately low-income, black sample in early midlife. | Mondi CF et al. | β | 2022 | β |
| Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC). | Tatar O et al. | β | 2022 | β |
| Relation of Cannabis Use to Elevated Atherosclerotic Cardiovascular Disease Risk Score. | Skipina TM et al. | β | 2022 | β |
| Sociodemographic and clinical correlates of cannabis dependence among Israeli combat veterans. | Asper A et al. | β | 2022 | β |
| The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier? | Mohamed A et al. | β | 2022 | β |
| Trajectories of Prescription Drug Misuse Among US Adults From Ages 18 to 50 Years. | McCabe SE et al. | β | 2022 | β |
| Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005-2019. | Hasin DS et al. | β | 2022 | β |
| Understanding the Potential Benefits of Cannabidiol for Patients With Schizophrenia: A Narrative Review. | Dyck GJB et al. | β | 2022 | β |
| Use of Marijuana: Effect on Brain Health: A Scientific Statement From the American Heart Association. | Testai FD et al. | β | 2022 | β |
| Using ecological momentary assessment and a portable device to quantify standard tetrahydrocannabinol units for cannabis flower smoking. | Trull TJ et al. | β | 2022 | β |
| Validity of the Single-Item Screen-Cannabis (SIS-C) for Cannabis Use Disorder Screening in Routine Care. | Matson TE et al. | β | 2022 | β |
| Workplace Supported Recovery from Substance Use Disorders: Defining the Construct, Developing a Model, and Proposing an Agenda for Future Research. | Frone MR et al. | β | 2022 | β |
| A comparison of cannabis protective behavioral strategies use across cultures and sex. | Richards DK et al. | β | 2021 | β |
| Acute objective and subjective intoxication effects of legal-market high potency THC-dominant versus CBD-dominant cannabis concentrates. | Drennan ML et al. | β | 2021 | β |
| Adolescent exposure to delta-9-tetrahydrocannabinol and ethanol heightens sensitivity to fear stimuli. | Smiley CE et al. | β | 2021 | β |
| Advancing the science on cannabis concentrates and behavioural health. | Bidwell LC et al. | β | 2021 | β |
| Adverse effects of heavy cannabis use: even plants can harm the brain. | Sideli L et al. | β | 2021 | β |
| Alcohol and Cannabis Use Disorder Symptom Severity, Conduct Disorder, and Callous-Unemotional Traits and Impairment in Expression Recognition. | Blair RJR et al. | β | 2021 | β |
| Alcohol Use Disorder and Cannabis Use Disorder Symptomatology in Adolescents and Aggression: Associations With Recruitment of Neural Regions Implicated in Retaliation. | Blair RJR et al. | β | 2021 | β |
| Alcohol use disorder and cannabis use disorder symptomatology in adolescents is associated with dysfunction in neural processing of future events. | Aloi J et al. | β | 2021 | β |
| An experimental investigation of peer rejection and social anxiety on alcohol and cannabis use willingness: Accounting for social contexts and use cues in the laboratory. | Cloutier RM et al. | β | 2021 | β |
| A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness. | Kozak K et al. | β | 2021 | β |
| Between- and within-group effects of alcohol and cannabis co-use on AUD/CUD in the NSDUH 2002-2019. | Waddell JT | β | 2021 | β |
| Burden of cannabis use and disorder in the U.S. veteran population: Psychiatric comorbidity, suicidality, and service utilization. | Hill ML et al. | β | 2021 | β |
| Cannabis and Depression. | Feingold D et al. | β | 2021 | β |
| Cannabis Associated Mental Health Effects: A Review. | Kancherla N et al. | β | 2021 | β |
| Cannabis use and cannabis use disorder. | Connor JP et al. | β | 2021 | β |
| Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches. | Kondev V et al. | β | 2021 | β |
| Cannabis use disorder and post-traumatic stress disorder: The prevalence of comorbidity in veterans of recent conflicts. | Bryan JL et al. | β | 2021 | β |
| Cannabis use disorder treatment use and perceived treatment need in the United States: Time trends and age differences between 2002 and 2019. | Askari MS et al. | β | 2021 | β |
| Cannabis users demonstrate enhanced neural reactivity to reward: An event-related potential and time-frequency EEG study. | Crane NA et al. | β | 2021 | β |
| Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys. | Onaemo VN et al. | β | 2021 | β |
| Comparative associations of problematic alcohol and cannabis use with suicidal behavior in U.S. military veterans: A population-based study. | Hill ML et al. | β | 2021 | β |
| Correlates of Cannabis Use Disorders among urban women of color: childhood abuse, relationship with spouse/partner, and media exposure. | Lee JY et al. | β | 2021 | β |
| Demographic risk factors for co-occurring suicidality and cannabis use disorders: Findings from a nationally representative United States sample. | Kelly LM et al. | β | 2021 | β |
| Development and validation of a cannabis cue stimulus set. | Macatee RJ et al. | β | 2021 | β |
| Editorial: Psychological Aspects of Cannabis Use and Cannabis Use Disorder. | Feingold D et al. | β | 2021 | β |
| Evaluating spin in the abstracts of systematic reviews and meta-analyses on cannabis use disorder. | Corcoran A et al. | β | 2021 | β |
| Examining Associations Between Licensed and Unlicensed Outlet Density and Cannabis Outcomes From Preopening to Postopening of Recreational Cannabis Outlets. | Pedersen ER et al. | β | 2021 | β |
| Fatty acid amide hydrolase is lower in young cannabis users. | Jacobson MR et al. | β | 2021 | β |
| From Enchantment to Disillusion: A Narrative Exploration of Cannabis Use Disorder Among Young Israeli Combat Veterans. | Serebro M et al. | β | 2021 | β |
| Gender-based differential item functioning in the Cannabis-Associated Problems Questionnaire: A replication and extension. | Altman BR et al. | β | 2021 | β |
| Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research. | Kayser RR et al. | β | 2021 | β |
| Impact of a computerized intervention for high distress intolerance on cannabis use outcomes: A randomized controlled trial. | Macatee RJ et al. | β | 2021 | β |
| Impact of Users' Attitudes Toward Anonymous Internet Interventions for Cannabis vs. Alcohol Use: A Secondary Analysis of Data From Two Clinical Trials. | Romero D et al. | β | 2021 | β |
| Impaired motor cortical plasticity associated with cannabis use disorder in young adults. | Martin-Rodriguez JF et al. | β | 2021 | β |
| Individual associations of adolescent alcohol use disorder versus cannabis use disorder symptoms in neural prediction error signaling and the response to novelty. | Aloi J et al. | β | 2021 | β |
| Interventions for cannabis use disorder. | Winters KC et al. | β | 2021 | β |
| Life Stressors and Sleep Problems as Predictors of the Likelihood of Lifetime Cannabis Use among Black Adults with Criminal Justice Contact. | Archibald PC et al. | β | 2021 | β |
| Multiple Substance Use Disorders and Self-Reported Cognitive Function in U.S. Adults: Associations and Sex-Differences in a Nationally Representative Sample. | Bourgault Z et al. | β | 2021 | β |
| Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions. | Brown JD et al. | β | 2021 | β |
| Non-abstinent treatment outcomes for cannabis use disorder. | Levin FR et al. | β | 2021 | β |
| Patterns of brain function associated with cannabis cue-reactivity in regular cannabis users: a systematic review of fMRI studies. | Sehl H et al. | β | 2021 | β |
| Patterns of Cannabis Use Among Individuals with Obsessive-Compulsive Disorder: Results from an Internet Survey. | Kayser RR et al. | β | 2021 | β |
| Perceived impacts of the COVID-19 pandemic on cannabis-using emerging adults. | Bonar EE et al. | β | 2021 | β |
| Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder. | D'Souza DC et al. | β | 2021 | β |
| Prevalence of cardiac arrhythmias in cannabis use disorder related hospitalizations in teenagers from 2003 to 2016 in the United States. | Umapathi KK et al. | β | 2021 | β |
| Preventive interventions targeting cannabis use and related harms in people with psychosis: A systematic review. | Coronado-Montoya S et al. | β | 2021 | β |
| Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adults. | Gutkind S et al. | β | 2021 | β |
| Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review. | Lees R et al. | β | 2021 | β |
| Relations between impulsive personality traits, alcohol and cannabis co-use, and negative alcohol consequences: A test of cognitive and behavioral mediators. | Waddell JT et al. | β | 2021 | β |
| Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders. | Navarrete F et al. | β | 2021 | β |
| Serum Proteomic Analysis of Cannabis Use Disorder in Male Patients. | Alasmari F et al. | β | 2021 | β |
| The Green Sheep: Exploring the Perceived Risks and Benefits of Cannabis Among Young Military Members and Veterans. | Clary KL et al. | β | 2021 | β |
| The impact of state cannabis legislation, county-level socioeconomic and dog-level characteristics on reported cannabis poisonings of companion dogs in the USA (2009-2014). | Howard-Azzeh M et al. | β | 2021 | β |
| The Impact of THC and CBD in Schizophrenia: A Systematic Review. | Ahmed S et al. | β | 2021 | β |
| The Psychosocial Predictors and Day-Level Correlates of Substance Use Among Participants Recruited via an Online Crowdsourcing Platform in the United States: Daily Diary Study. | Jain JP et al. | β | 2021 | β |
| The relationship between cannabis use and cognition in people with bipolar disorder: A systematic scoping review. | Jordan Walter T et al. | β | 2021 | β |
| Trends over time in adult cannabis use: A review of recent findings. | Hasin D et al. | β | 2021 | β |
| Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws. | Hasin DS et al. | β | 2021 | β |
| Which came first: Cannabis use or deficits in impulse control? | Rinehart L et al. | β | 2021 | β |
| Alcohol Use Disorder, But Not Cannabis Use Disorder, Symptomatology in Adolescents Is Associated With Reduced Differential Responsiveness to Reward Versus Punishment Feedback During Instrumental Learning. | Aloi J et al. | β | 2020 | β |
| An exploratory study of cannabis use pattern and treatment seeking in patients attending an addiction treatment facility. | Sarkar S et al. | β | 2020 | β |
| Assessing the Role of Cannabis Use on Cortical Surface Structure in Adolescents and Young Adults: Exploring Gender and Aerobic Fitness as Potential Moderators. | Sullivan RM et al. | β | 2020 | β |
| Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016. | CerdΓ‘ M et al. | β | 2020 | β |
| Association of Depression With Past-Month Cannabis Use Among US Adults Aged 20 to 59 Years, 2005 to 2016. | Gorfinkel LR et al. | β | 2020 | β |
| Associations between Psychiatric Disorders and Cannabis-Related Disorders Documented in Electronic Health Records. | Campbell A et al. | β | 2020 | β |
| A systematic review of technology-based psychotherapeutic interventions for decreasing cannabis use in patients with psychosis. | Tatar O et al. | β | 2020 | β |
| A web-based episodic specificity and future thinking session modulates delay discounting in cannabis users. | Sofis MJ et al. | β | 2020 | β |
| A Web-Based Program for Cannabis Use and Psychotic Experiences in Young People (Keep It Real): Protocol for a Randomized Controlled Trial. | Hides L et al. | β | 2020 | β |
| Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review. | Hasin D et al. | β | 2020 | β |
| Cannabis use, depression and suicidal ideation in adolescence: direction of associations in a population based cohort. | Bolanis D et al. | β | 2020 | β |
| Cannabis use disorder among veterans: Comorbidity and mental health treatment utilization. | Ecker AH et al. | β | 2020 | β |
| Cannabis Use Disorder Impairs Motor Cortical Plasticity. | Liu X et al. | β | 2020 | β |
| Cannabis Use in Inpatients With Schizophrenia Spectrum Disorders at a Community Hospital. | Olayinka O et al. | β | 2020 | β |
| Cannabis use, problem-gambling severity, and psychiatric disorders: Data from the National Epidemiological Survey on Alcohol and Related Conditions. | Hammond CJ et al. | β | 2020 | β |
| Cigarette smoking quit ratios among adults in the USA with cannabis use and cannabis use disorders, 2002-2016. | Weinberger AH et al. | β | 2020 | β |
| Deconstructing the neurobiology of cannabis use disorder. | Ferland JN et al. | β | 2020 | β |
| Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. | Tomko RL et al. | β | 2020 | β |
| Does cannabis use increase anxiety disorders? A literature review. | Shalit N et al. | β | 2020 | β |
| Early and Late Adolescent Factors that Predict Co-use of Cannabis with Alcohol and Tobacco in Young Adulthood. | D'Amico EJ et al. | β | 2020 | β |
| Evidence for the Endocannabinoid System as a Therapeutic Target in the Treatment of Cannabis Use Disorder. | Martin EL et al. | β | 2020 | β |
| Factor Structure of the Cannabis Use Disorders Identification Test Revised (CUDIT-R) for Men and Women. | Risi MM et al. | β | 2020 | β |
| Greater delay discounting and cannabis coping motives are associated with more frequent cannabis use in a large sample of adult cannabis users. | Sofis MJ et al. | β | 2020 | β |
| Increased Resting State Triple Network Functional Connectivity in Undergraduate Problematic Cannabis Users: A Preliminary EEG Coherence Study. | Imperatori C et al. | β | 2020 | β |
| Is Recovery from Cannabis Dependence Possible? Factors that Help or Hinder Recovery in a National Sample of Canadians with a History of Cannabis Dependence. | Fuller-Thomson E et al. | β | 2020 | β |
| Marijuana and the Pediatric Population. | Dharmapuri S et al. | β | 2020 | β |
| Marijuana Use and Potential Implications of Marijuana Legalization. | Grigsby TM et al. | β | 2020 | β |
| Marriage and reductions in men's alcohol, tobacco, and cannabis use. | Salvatore JE et al. | β | 2020 | β |
| Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association. | Page RL et al. | β | 2020 | β |
| Molecular Mechanism and Cannabinoid Pharmacology. | Schurman LD et al. | β | 2020 | β |
| Obsessive-Compulsive Symptoms and Cannabis Misuse: The Explanatory Role of Cannabis Use Motives. | Bakhshaie J et al. | β | 2020 | β |
| Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review. | Kondo KK et al. | β | 2020 | β |
| Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: Systematic review and meta-analysis. | Hunt GE et al. | β | 2020 | β |
| Probability and correlates of transition from cannabis use to DSM-5 cannabis use disorder: Results from a large-scale nationally representative study. | Feingold D et al. | β | 2020 | β |
| Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems. | Callaghan RC et al. | β | 2020 | β |
| Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions. | Pacek LR et al. | β | 2020 | β |
| Reviewing the Potential of Psychedelics for the Treatment of PTSD. | Krediet E et al. | β | 2020 | β |
| Risk for Substance Use Disorders in young adulthood: Associations with developmental experiences of homelessness, foster care, and adverse childhood experiences. | Moss HB et al. | β | 2020 | β |
| Routine Assessment of Symptoms of Substance Use Disorders in Primary Care: Prevalence and Severity of Reported Symptoms. | Sayre M et al. | β | 2020 | β |
| Severity of DSM-5 cannabis use disorders in a nationally representative sample of sexual minorities. | Boyd CJ et al. | β | 2020 | β |
| Sex and Strain Variation in Initial Sensitivity and Rapid Tolerance to Ξ9-Tetrahydrocannabinol. | Parks C et al. | β | 2020 | β |
| Sibling comparisons elucidate the associations between educational attainment polygenic scores and alcohol, nicotine and cannabis. | Salvatore JE et al. | β | 2020 | β |
| The Intersection between Spliff Usage, Tobacco Smoking, and Having the First Joint after Waking. | Kumar N et al. | β | 2020 | β |
| Trends in documented cannabis use disorder among hospitalized adult epilepsy patients in the United States. | Lekoubou A et al. | β | 2020 | β |
| U.S. Adults With Pain, a Group Increasingly Vulnerable to Nonmedical Cannabis Use and Cannabis Use Disorder: 2001-2002 and 2012-2013. | Hasin DS et al. | β | 2020 | β |
| Violence and Cannabis Use: A Focused Review of a Forgotten Aspect in the Era of Liberalizing Cannabis. | Dellazizzo L et al. | β | 2020 | β |
| What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis. | Leung J et al. | β | 2020 | β |
| Ξ-Tetrahydrocannabinol Increases Dopamine D1-D2 Receptor Heteromer and Elicits Phenotypic Reprogramming in Adult Primate Striatal Neurons. | Hasbi A et al. | β | 2020 | β |
| An Examination of Comorbid Psychiatric Disorders in Disordered Gamblers Versus Other Substance-Related Disorders. | Nicholson R et al. | β | 2019 | β |
| An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use. | Budney AJ et al. | β | 2019 | β |
| A prospective study of nonmedical use of prescription opioids during adolescence and subsequent substance use disorder symptoms in early midlife. | McCabe SE et al. | β | 2019 | β |
| A Reciprocal Model of Pain and Substance Use: Transdiagnostic Considerations, Clinical Implications, and Future Directions. | Ditre JW et al. | β | 2019 | β |
| Association of Marijuana Use with Changes in Cognitive Processing Speed and Flexibility for 17 Years in HIV-Seropositive and HIV-Seronegative Men. | Okafor CN et al. | β | 2019 | β |
| Associations Between Marijuana Use and Involuntary Job Loss in the United States: Representative Longitudinal and Cross-Sectional Samples. | Okechukwu CA et al. | β | 2019 | β |
| Associations of Parental Marijuana Use With Offspring Marijuana, Tobacco, and Alcohol Use and Opioid Misuse. | Madras BK et al. | β | 2019 | β |
| Associations of PTSD, chronic pain, and their comorbidity on cannabis use disorder: Results from an American nationally representative study. | Bilevicius E et al. | β | 2019 | β |
| Cannabis and mental illness: a review. | Lowe DJE et al. | β | 2019 | β |
| Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016. | Santaella-Tenorio J et al. | β | 2019 | β |
| Cannabis use disorders among adults in the United States during a time of increasing use of cannabis. | Compton WM et al. | β | 2019 | β |
| Cannabis use patterns at the dawn of US cannabis reform. | Kumar N et al. | β | 2019 | β |
| CB<sub>1</sub> positive allosteric modulation attenuates Ξ<sup>9</sup>-THC withdrawal and NSAID-induced gastric inflammation. | Trexler KR et al. | β | 2019 | β |
| Context matters: Characteristics of solitary versus social cannabis use. | Spinella TC et al. | β | 2019 | β |
| Determining Risks for Cannabis Use Disorder in the Face of Changing Legal Policies. | Taylor M et al. | β | 2019 | β |
| Distress intolerance moderation of motivated attention to cannabis and negative stimuli after induced stress among cannabis users: an ERP study. | Macatee RJ et al. | β | 2019 | β |
| Distress tolerance and cannabis craving: The impact of laboratory-induced distress. | Buckner JD et al. | β | 2019 | β |
| DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults. | Livne O et al. | β | 2019 | β |
| Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies. | Sloan ME et al. | β | 2019 | β |
| Endocannabinoid System Alterations in Posttraumatic Stress Disorder: A Review of Developmental and Accumulative Effects of Trauma. | Bassir Nia A et al. | β | 2019 | β |
| Exploring the relationship between polygenic risk for cannabis use, peer cannabis use and the longitudinal course of cannabis involvement. | Johnson EC et al. | β | 2019 | β |
| Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers. | Haney M et al. | β | 2019 | β |
| Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender, 2004-2013. | Mauro CM et al. | β | 2019 | β |
| Longitudinal Associations Between Life Satisfaction and Cannabis Use Initiation, Cessation, and Disorder Symptom Severity in a Cohort of Young Swiss Men. | Deligianni ML et al. | β | 2019 | β |
| Patient Characteristics Predicting Abstinence in Substance Use Disorder Patients With Comorbid Mental Disorders. | van Hagen LJ et al. | β | 2019 | β |
| Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review | Kondo K et al. | β | 2019 | β |
| Prevalence and correlates of cannabis poisoning diagnosis in a national emergency department sample. | Salas-Wright CP et al. | β | 2019 | β |
| Priming primary care providers to engage in evidence-based discussions about cannabis with patients. | Kansagara D et al. | β | 2019 | β |
| Psychiatric and medical correlates of DSM-5 eating disorders in a nationally representative sample of adults in the United States. | Udo T et al. | β | 2019 | β |
| Psychosocial moderation of polygenic risk for cannabis involvement: the role of trauma exposure and frequency of religious service attendance. | Meyers JL et al. | β | 2019 | β |
| Severity of Substance Use Disorder: Utility as an Outcome in Clinical Settings. | Dacosta-SΓ‘nchez D et al. | β | 2019 | β |
| Shared Neural Correlates Underlying Addictive Disorders and Negative Urgency. | Um M et al. | β | 2019 | β |
| The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with meta-analysis and meta-regression. | Pinto JV et al. | β | 2019 | β |
| The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7βUS health systems. | Lapham GT et al. | β | 2019 | β |
| The relationship among depressive symptoms, urgency, and problematic alcohol and cannabis use in community adults. | Um M et al. | β | 2019 | β |
| The therapeutic role of emotion regulation and coping strategies during a stand-alone DBT Skills training program for alcohol use disorder and concurrent substance use disorders. | Cavicchioli M et al. | β | 2019 | β |
| The University of Vermont Wellness Environment: Feasibility and Initial Results of a College Undergraduate Health-Promoting Program. | Bai Y et al. | β | 2019 | β |
| Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada. | Jutras-Aswad D et al. | β | 2019 | β |
| Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings. | Hasin DS et al. | β | 2019 | β |
| Tobacco and cannabis co-use and interrelatedness among adults. | Akbar SA et al. | β | 2019 | β |
| Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences. | McClure EA et al. | β | 2019 | β |
| Trajectories of prescription drug misuse during the transition from late adolescence into adulthood in the USA: a national longitudinal multicohort study. | McCabe SE et al. | β | 2019 | β |
| Types of cannabis and tobacco/nicotine co-use and associated outcomes in young adulthood. | Tucker JS et al. | β | 2019 | β |
| Typology of cannabis use among adults: A latent class approach to risk and protective factors. | Manning K et al. | β | 2019 | β |
| Age Differences in Daily and Nondaily Cannabis Use in the United States, 2002-2014. | Mauro PM et al. | β | 2018 | β |
| A prospective observational study of problematic oral cannabinoid use. | Ware MA et al. | β | 2018 | β |
| A search algorithm for identifying likely users and non-users of marijuana from the free text of the electronic medical record. | Keyhani S et al. | β | 2018 | β |
| A Survey of Payer Perspectives on Cannabis Use Disorder. | Kiselica AM et al. | β | 2018 | β |
| Cannabis regulatory science: risk-benefit considerations for mental disorders. | Borodovsky JT et al. | β | 2018 | β |
| Childhood interpersonal violence and adult alcohol, cannabis, and tobacco use disorders: variation by race/ethnicity? | Meyers JL et al. | β | 2018 | β |
| Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: emerging disparities in vulnerable populations. | Weinberger AH et al. | β | 2018 | β |
| Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders. | Reeves LE et al. | β | 2018 | β |
| Concurrent use of alcohol with other drugs and DSM-5 alcohol use disorder comorbid with other drug use disorders: Sociodemographic characteristics, severity, and psychopathology. | Saha TD et al. | β | 2018 | β |
| Demographic and clinical correlates of substance use disorders in first episode psychosis. | Brunette MF et al. | β | 2018 | β |
| Difficulties regulating positive emotions and alcohol and drug misuse: A path analysis. | Weiss NH et al. | β | 2018 | β |
| Distress intolerance moderation of neurophysiological markers of response inhibition after induced stress: Relations with cannabis use disorder. | Macatee RJ et al. | β | 2018 | β |
| DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles. | Kerridge BT et al. | β | 2018 | β |
| Effects of behavioural activation on substance use and depression: a systematic review. | MartΓnez-Vispo C et al. | β | 2018 | β |
| Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States. | Hasin DS et al. | β | 2018 | β |
| How Collegiate Fraternity and Sorority Involvement Relates to Substance Use During Young Adulthood and Substance Use Disorders in Early Midlife: A National Longitudinal Study. | McCabe SE et al. | β | 2018 | β |
| Impact of cannabis legalization on treatment and research priorities for cannabis use disorder. | Sahlem GL et al. | β | 2018 | β |
| Intersection of stress and gender in association with transitions in past year DSM-5 substance use disorder diagnoses in the United States. | Verplaetse TL et al. | β | 2018 | β |
| Is recovery from cannabis use problems different from alcohol and other drugs? Results from a national probability-based sample of the United States adult population. | Kelly JF et al. | β | 2018 | β |
| Medical marijuana laws and adolescent marijuana use in the United States: a systematic review and meta-analysis. | Sarvet AL et al. | β | 2018 | β |
| Negative affectivity as a mechanism underlying perceived distress tolerance and cannabis use problems, barriers to cessation, and self-efficacy for quitting among urban cannabis users. | Manning K et al. | β | 2018 | β |
| Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis. | Butelman ER et al. | β | 2018 | β |
| Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice. | Trexler KR et al. | β | 2018 | β |
| Prevalence of Behavioral Health Conditions Across Frequency of Cannabis Use Among Adult Primary Care Patients in Washington State. | Lapham GT et al. | β | 2018 | β |
| Psychosocial functioning among regular cannabis users with and without cannabis use disorder. | Foster KT et al. | β | 2018 | β |
| Spatial Epidemiology of Alcohol- and Drug-Related Health Problems Among Northern Plains American Indians: Nebraska and South Dakota, 2007 to 2012. | Ponicki WR et al. | β | 2018 | β |
| Substance-related disorders: A review of prevalence and correlates among patients with chronic pain. | Martel MO et al. | β | 2018 | β |
| The Association Between Cannabis Use and Aberrant Behaviors During Chronic Opioid Therapy for Chronic Pain. | DiBenedetto DJ et al. | β | 2018 | β |
| The association between perceived distress tolerance and cannabis use problems, cannabis withdrawal symptoms, and self-efficacy for quitting cannabis: The explanatory role of pain-related affective distress. | Manning K et al. | β | 2018 | β |
| The impact of PTSD clusters on cannabis use in a racially diverse trauma-exposed sample: An analysis from ecological momentary assessment. | Buckner JD et al. | β | 2018 | β |
| Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. | Mouhamed Y et al. | β | 2018 | β |
| Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. | McClure EA et al. | β | 2018 | β |
| Triple trajectories of alcohol use, tobacco use, and depressive symptoms as predictors of cannabis use disorders among urban adults. | Lee JY et al. | β | 2018 | β |
| US Epidemiology of Cannabis Use and Associated Problems. | Hasin DS | β | 2018 | β |
| Adolescents' Prescription Stimulant Use and Adult Functional Outcomes: A National Prospective Study. | McCabe SE et al. | β | 2017 | β |
| A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. | Gray KM et al. | β | 2017 | β |
| Associations between anhedonia and marijuana use escalation across mid-adolescence. | Leventhal AM et al. | β | 2017 | β |
| Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians. | Copeland WE et al. | β | 2017 | β |
| Cannabis use, attitudes, and legal status in the U.S.: A review. | Carliner H et al. | β | 2017 | β |
| Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. | McClure EA et al. | β | 2017 | β |
| Co-use of Alcohol and Cannabis: A Review. | Yurasek AM et al. | β | 2017 | β |
| DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample. | Hayley AC et al. | β | 2017 | β |
| Effect of oxytocin pretreatment on cannabis outcomes in a brief motivational intervention. | Sherman BJ et al. | β | 2017 | β |
| Examination of cumulative effects of early adolescent depression on cannabis and alcohol use disorder in late adolescence in a community-based cohort. | Rhew IC et al. | β | 2017 | β |
| Fathers' Alcohol and Cannabis Use Disorder and Early Onset of Drug Use by Their Children. | Henry KL | β | 2017 | β |
| Frequency of Cannabis Use Among Primary Care Patients in Washington State. | Lapham GT et al. | β | 2017 | β |
| Identifying HIV care enrollees at-risk for cannabis use disorder. | Hartzler B et al. | β | 2017 | β |
| Longitudinal Studies on the Etiology of Cannabis Use Disorder: A Review. | Courtney KE et al. | β | 2017 | β |
| Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review. | Steenkamp MM et al. | β | 2017 | β |
| Marijuana use among young people in an era of policy change: what does recent evidence tell us? | Salas-Wright CP et al. | β | 2017 | β |
| Mechanisms Underlying Sex Differences in Cannabis Use. | Calakos KC et al. | β | 2017 | β |
| Multiple DSM-5 substance use disorders: A national study of US adults. | McCabe SE et al. | β | 2017 | β |
| Phenotypic and familial associations between childhood maltreatment and cannabis initiation and problems in young adult European-American and African-American women. | Grant JD et al. | β | 2017 | β |
| Predicting Persistent, Limited, and Delayed Problematic Cannabis Use in Early Adulthood: Findings From a Longitudinal Study. | Hill S et al. | β | 2017 | β |
| Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States. | Kerridge BT et al. | β | 2017 | β |
| Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States. | Wu LT et al. | β | 2017 | β |
| Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States. | Hartzler B et al. | β | 2017 | β |
| Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders. | Suryadevara U et al. | β | 2017 | β |
| Quality of life and recreational cannabis use. | Goldenberg M et al. | β | 2017 | β |
| Self-reported cognitive scales in a US National Survey: reliability, validity, and preliminary evidence for associations with alcohol and drug use. | Aharonovich E et al. | β | 2017 | β |
| Sex Differences in Cannabis Use Disorder Diagnosis Involved Hospitalizations in the United States. | Zhu H et al. | β | 2017 | β |
| Stigma and substance use disorders: an international phenomenon. | Yang LH et al. | β | 2017 | β |
| Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11. | Saunders JB | β | 2017 | β |
| The association between alcohol use trajectories from adolescence to adulthood and cannabis use disorder in adulthood: a 22-year longitudinal study. | Lee JY et al. | β | 2017 | β |
| The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample. | Krawczyk N et al. | β | 2017 | β |
| The endocannabinoid system as a target for addiction treatment: Trials and tribulations. | Sloan ME et al. | β | 2017 | β |
| The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014. | Carliner H et al. | β | 2017 | β |
| Trends and correlates of marijuana use among late middle-aged and older adults in the United States, 2002-2014. | Salas-Wright CP et al. | β | 2017 | β |
| US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013. | Hasin DS et al. | β | 2017 | β |
| Changing perspectives on marijuana use during early adolescence and young adulthood: Evidence from a panel of cross-sectional surveys. | Salas-Wright CP et al. | β | 2016 | β |
| Practical Aspects of Discussing Marijuana in a New Era. | Lenoue SR et al. | β | 2016 | β |
| Recreational cannabis legalisation: details will determine mental health effects. | Hill KP | β | 2016 | β |
| Stressful Events and Other Predictors of Remission from Drug Dependence in the United States: Longitudinal Results from a National Survey. | McCabe SE et al. | β | 2016 | β |
| The Epidemiology of DSM-5 Cannabis Use Disorders Among U.S. Adults: Science to Inform Clinicians Working in a Shifting Social Landscape. | Compton WM et al. | β | 2016 | β |
| WHY NOT POT?: A Review of the Brain-based Risks of Cannabis. | MacDonald K et al. | β | 2016 | β |